A Phase II Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Chondrosarcoma
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Pazopanib (Primary)
- Indications Chondrosarcoma
- Focus Therapeutic Use
- 22 Mar 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 05 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Feb 2018.